Mylan says US court will not block Apotex's plans for generic Paxil CR
This article was originally published in Scrip
Executive Summary
Mylan has confirmed that its motion for a preliminary injunction against GlaxoSmithKline and Apotex pertaining to generic Paxil CR (paroxetine extended-release tablets) was denied at an 18 October hearing in the US District Court for the District of New Jersey.